CIK 0001759425 · Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831281555
- Phone
- 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,138,950
- in 6 filings, $4.8M under 10b5-1 plans
Net −$11,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-19 | GREY MICHAEL G Director | Sale 10b5-1 | −50,000 | $78.00 | $3.9M | 0 |
| 2025-12-19 | GREY MICHAEL G Director | Option exercise · Stock Option (right to buy) 10b5-1 | −50,000 | 181,176 | ||
| 2025-12-18 | Ramasastry Saira Director | Option exercise 10b5-1 | +2,000 | $23.51 | $47K | 2,000 |
| 2025-12-18 | Ramasastry Saira Director | Sale 10b5-1 | −1,000 | $69.46 | $69K | 1,000 |
| 2025-12-18 | Ramasastry Saira Director | Sale 10b5-1 | −1,000 | $70.00 | $70K | 0 |
| 2025-12-18 | Ramasastry Saira Director | Option exercise · Stock Option (right to buy) 10b5-1 | −2,000 | 15,000 | ||
| 2025-12-01 | GREY MICHAEL G Director | Option exercise 10b5-1 | +50,000 | $2.94 | $147K | 50,000 |
| 2025-12-01 | GREY MICHAEL G Director | Sale 10b5-1 | −50,000 | $74.00 | $3.7M | 0 |
| 2025-12-01 | GREY MICHAEL G Director | Option exercise · Stock Option (right to buy) 10b5-1 | −50,000 | 231,176 | ||
| 2025-11-21 | GREY MICHAEL G Director | Option exercise 10b5-1 | +50,000 | $2.94 | $147K | 50,000 |
| 2025-11-21 | GREY MICHAEL G Director | Sale 10b5-1 | −50,000 | $70.00 | $3.5M | 0 |
| 2025-11-21 | GREY MICHAEL G Director | Option exercise · Stock Option (right to buy) 10b5-1 | −50,000 | 281,176 | ||
| 2025-11-18 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise | +19,133 | $19.24 | $368K | 158,034 |
| 2025-11-18 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise · Employee Stock Option (right to buy) | −19,133 | 150,867 | ||
| 2025-09-12 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale | −9,578 | $76.01 | $728K | 39,945 |
| 2025-09-11 | Brege Laura Director | Option exercise | +17,000 | $15.00 | $255K | 32,703 |
| 2025-09-11 | Brege Laura Director | Sale | −15,509 | $74.34 | $1.2M | 17,194 |
| 2025-09-11 | Brege Laura Director | Sale | −1,491 | $75.07 | $112K | 15,703 |
| 2025-09-11 | Brege Laura Director | Option exercise · Stock Option (right to buy) | −17,000 | 0 | ||
| 2025-09-11 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Option exercise | +18,333 | 49,523 |
Page 10 of 15 · 294 trades